CAR T-Cell Therapy
Chimeric antigen receptor T cells ...
169
Description

CAR T-Cell Therapy

Chimeric antigen receptor T cells (CAR T cells): type of autologous therapy; T lymphocytes collected from the patient, genetically modified via transfection with a gene encoding a chimeric antigen receptor (CAR) that directs the T-cells against a selected antigen on the patient’s tumor.

CARs: consist of an extracellular domain that targets and binds a tumor antigen (i.e. CD19 in B-cell NHL and ALL) attached to intracellular domains that signal for T-cell activation (see figure). 

TOXICITIES

 • Cytokine-release syndrome (CRS)

 • CAR-T-cell-related encephalopathy syndrome (CRES)

 • CAR-T-cell-related hemophagocytic lymphohistiocytosis (HLH)/MAS



#CARTCell #Therapy #management #oncology #toxicity #toxicities #diagnosis 
Contributed by

MGH White Book Manual
@MGHWhiteBook
Account created for the MGH Internal Medicine Housestaff Manual "White Book" - https://stk10.github.io/MGH-Docs/WhiteBook-2019-2020.pdf
Medical jobs
view all

0 Comments

Related content